4 items

Success of gene therapy for a form of inherited blindness depends on timing

September 9, 2019

Using a canine model of the vision disorder Leber congenital amaurosis, Penn researchers found that photoreceptor cells continue to deteriorate after treatment if it is given too late.

NIH vision researcher T. Michael Redmond recognized with Champalimaud Vision Award

September 4, 2018

Vision researcher, T. Michael Redmond, Ph.D., chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, is a recipient of the 2018 António Champalimaud Vision Award for foundational science discoveries about the molecular

With LCA Gene Therapy, a Rare Glimpse of the Adult Brain Adapting to New Experience

August 4, 2015

When people lose the ability to see, how do the visual parts of the brain change in response? And if they regain their sight, are the changes reversed?

NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy

May 1, 2015

Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes vision loss starting in childhood, improved patients’ eyesight and the sensitivity of the retina within weeks of treatment.